Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C W ECKER FA
Original Assignee
C W ECKER FA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C W ECKER FAfiledCriticalC W ECKER FA
Priority to DE1953E0004369priorityCriticalpatent/DE1663186U/en
Publication of DE1663186UpublicationCriticalpatent/DE1663186U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Description
! ocl. X&teilt a : Lizen zeinaa-depiSL aesariasm. tasTKMMjtJhaHHRMBaM&hss*ItiM&ettiMMpaaa<lgt iStaakßKüMm&g<aItwiEDM dez, Z. B.- etimSchaftdurchmenner vm 4, zu h&t, iat an dem a1U4n ßUd&
eiU-Imk-1=Pt 2£t ctem 3. rachen alar kal-teit Ire&* ange-atumtt.Zag andore lbd* da, % Bqlzeng IßtShaasNHMHKH'iK8] N] Kf istas. daBaBMSLläb<Kt ! HE-lK<NtQ&e&Kf% ärezaaafaMaTpsas-ssxBts : aBwz Eadaaf) Ep BaM8Ia. tSLtMd&adSKK&&Cß ? HBMH1N& dtS* tcmt-. 1e : t wbC..1I\1ZCÀ ti... zràtm& mul'. aexadLe wdsMkMMPaMaK&Haimm<ßt-ke : I. 1ë : ã. 1io1. seaa -f : ;, 1fÚ4ee-ls waäaR& gias Bagsm et sa. di Me*tMdEEMt : ScseB<aäS dM<- BSaMK8acttadüjJt<&KPSaMman KpgaeIBaaHHfaMKpader Senkkapf b ilm kaztow Zuntnadj& ang « tamht Ist mi
« deseenX&IMMajEaänasRB : &JSKb&, - - -.-gegtellt iatl, lat clie-serstellung vollkwu » a amtl « t.wodurch gron » mat-erzi « it igtlksNKNMMIMhtjnMLaNNdJaia webet e SttEBeit dareSasaamendraett. hIbSTMaEsß assa iaIgestellt Ia is ieL SazstaIsBd<aeä<& vekoBBea. g ?
&tleDa de klHa au : t' 1ml : ; : -.. 1. 8 her- IEB. $sQswr<r ertil <r6<ht230he--halb-., f « 6e&<. B<s@paatBMc M-SMe'EEe ! MMMaat. a-m
ae&.,.. &-.-iaHEB-< ? aHz am )) am BaMwr t'ei* d ! ocl. X & shares a: Lizen zeina a-depiSL aesariasm. tasTKMMjtJhaHHRMBaM & hss * ItiM & ettiMMpaaa <lgt iStaakßKüMm & g <aItwiE DM dec, ZB- etim Shaft diameter vm 4, to h & t, iat on the a1U4n ßUd & eiU-Imk- 1 = Pt 2 £ t ctem 3rd rachen alar kal-teit Ire & * an- atumtt. Zag andore lbd * da,% Bqlzeng eats ShaasNHMHKH'iK8] N] Kf istas. daBaBMSLläb <Kt! HE- lK <NtQ & e & Kf% ärezaaafaMaTpsas- ssx Bts: aBwz Eadaaf) Ep BaM8Ia. t SLtMd & adSKK && Cß? HBMH1N & dtS * tcmt - . 1e: t wbC .. 1I \ 1ZCÀ ti ... zràtm & mul '. a exadLe wd sMkMMPaMaK & Haimm <ß- ke: I. 1ë: ã. 1io1. seaa -f:;, 1fÚ4e e-ls waäaR & gias Bagsm et sa. di Me * tMdEEMt: ScseB <aäS dM < - BSaMK8acttadüjJt <& KP SaMman KpgaeIBaaHHfaMKpa the sink cap b ilm kaztow Zuntnadj & ang «tamht ist mi« deseen X & IMMajEaänasRB: & JSKb & , - - -. - gegtellt iatl, lat clie-production vollkwu »a amtl« t. whereby gron »mat-erzi« it igtlk sNKNMMIMhtjnMLaNNdJaia weave e SttEBeit dare Sasaame drape. HIbSTMASß assa ia I. put Ia is ieL SazstaIsBd <aeä <& vekoBBea. g? & tle Since the klHa au: t '1ml:; : - .. 1. 8 her- I EB. $ sQswr <r ertil <r6 <ht 230he - half- ., f «6e &<. B <s @ paatBMc M-SMe'EEe! MMMaat. am ae &., .. & - .-iaHEB- <? aHz am)) am BaMwr t ' ei * d
Claims (1)
Sekut x &na eemeh--t
IaaMas&MaKäEEEB&BtstaBdedaI&K&&Mt&äNESt<EaKB<M<&HßbMMMmfi&aMMHHBC<MSHd&M&af iBi& ee aaM am m-sa Sa EC 23M&-'-. grses-aa aaBSBtaa&SBSaaEßB ssagMa. a e) . ass4 » V-eadsqadMM eEaM &MM ss aawmagsa
Sekut x & na eemeh - t
IaaMas & MaKäEEEB & BtstaBdedaI & K && Mt & ÄNESt <EaKB <M <& HßbMMMmfi & aMMHHBC <MSHd & M & af iBi & ee aaM am m-sa Sa EC 23M & - '-. grses-aa aaBSBtaa & SBSaaEßB ssagMa. ae). ass 4 »V- eadsqadMM eEaM & MM ss aawmagsa
Dolutegravir versus placebo in subjects harbouring HIV-1 with integrase inhibitor resistance associated substitutions: 48-week results from VIKING-4, a randomized study
Preventive efficacy of four or six monthly oral doses of 24 µg/kg moxidectin compared to six monthly doses of Heartgard® Plus or Interceptor® Plus against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs
Atorvastatin and the influence on postoperative atrial fibrillation after surgical aortic valve replacement (STARC) in adults at Odense University Hospital, Denmark: study protocol for a randomised controlled trial